These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14652987)

  • 41. Managing type 2 diabetes: going beyond glycemic control.
    Stolar MW; Hoogwerf BJ; Gorshow SM; Boyle PJ; Wales DO
    J Manag Care Pharm; 2008 Jun; 14(5 Suppl B):s2-19. PubMed ID: 18597582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inpatient management of diabetes: an increasing challenge to the hospitalist physician.
    Umpierrez GE
    J Hosp Med; 2007; 2 Suppl 1():33-5. PubMed ID: 17311239
    [No Abstract]   [Full Text] [Related]  

  • 43. Steroid hyperglycemia.
    Khurana A; Vinayek N
    J Hosp Med; 2007 Jul; 2(4):285; author reply 285-6. PubMed ID: 17705218
    [No Abstract]   [Full Text] [Related]  

  • 44. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
    MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
    [No Abstract]   [Full Text] [Related]  

  • 45. Reevaluating goals of insulin therapy: perspectives from large clinical trials.
    Riddle MC; Yuen KC
    Endocrinol Metab Clin North Am; 2012 Mar; 41(1):41-56. PubMed ID: 22575406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action.
    Draznin B; Gilden J; Golden SH; Inzucchi SE; ; Baldwin D; Bode BW; Boord JB; Braithwaite SS; Cagliero E; Dungan KM; Falciglia M; Figaro MK; Hirsch IB; Klonoff D; Korytkowski MT; Kosiborod M; Lien LF; Magee MF; Masharani U; Maynard G; McDonnell ME; Moghissi ES; Rasouli N; Rubin DJ; Rushakoff RJ; Sadhu AR; Schwartz S; Seley JJ; Umpierrez GE; Vigersky RA; Low CC; Wexler DJ
    Diabetes Care; 2013 Jul; 36(7):1807-14. PubMed ID: 23801791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maintaining glycemic control when transitioning from infusion insulin: a protocol-driven, multidisciplinary approach.
    Ramos P; Childers D; Maynard G; Box K; Namba J; Stadalman K; Renvall M
    J Hosp Med; 2010 Oct; 5(8):446-51. PubMed ID: 20945469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inpatient hyperglycemia: slide through the scale but cover the bases first.
    Asudani D; Calles-Escandon J
    J Hosp Med; 2007; 2 Suppl 1():23-32. PubMed ID: 17311238
    [No Abstract]   [Full Text] [Related]  

  • 49. Perioperative Glycemic Control in Patients With Diabetes.
    Wolfe RC
    J Perianesth Nurs; 2018 Apr; 33(2):226-231. PubMed ID: 29452737
    [No Abstract]   [Full Text] [Related]  

  • 50. Subcutaneous insulin order sets and protocols: effective design and implementation strategies.
    Maynard G; Wesorick DH; O'Malley C; Inzucchi SE;
    J Hosp Med; 2008 Sep; 3(5 Suppl):29-41. PubMed ID: 18951386
    [No Abstract]   [Full Text] [Related]  

  • 51. Thiazolidinediones in the treatment of patients with Post-Transplant-Hyperglycemia or new-onset diabetes mellitus after renal transplantation (NODAT) - A new therapeutic option?
    Säemann MD; Krebs M
    Wien Klin Wochenschr; 2010 Apr; 122(7-8):198-202. PubMed ID: 20503018
    [No Abstract]   [Full Text] [Related]  

  • 52. Managing diabetes in patients with chronic liver disease.
    Khan R; Foster GR; Chowdhury TA
    Postgrad Med; 2012 Jul; 124(4):130-7. PubMed ID: 22913901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hitting the target for inpatient glycemic management.
    Seggelke SA
    Nurse Pract; 2011 May; 36(5):24-31; quiz 31-2. PubMed ID: 21487318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exercise and glycemic control in diabetes: benefits, challenges, and adjustments to pharmacotherapy.
    Gulve EA
    Phys Ther; 2008 Nov; 88(11):1297-321. PubMed ID: 18801852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resveratrol and diabetes: A critical review of clinical studies.
    Öztürk E; Arslan AKK; Yerer MB; Bishayee A
    Biomed Pharmacother; 2017 Nov; 95():230-234. PubMed ID: 28843911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of hyperglycemia in acute illness: supporting evidence and its limitations.
    Corathers SD; Falciglia M
    Nutrition; 2011 Mar; 27(3):276-81. PubMed ID: 20869205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Inzucchi SE; Bergenstal RM; Buse JB; Diamant M; Ferrannini E; Nauck M; Peters AL; Tsapas A; Wender R; Matthews DR
    Diabetologia; 2012 Jun; 55(6):1577-96. PubMed ID: 22526604
    [No Abstract]   [Full Text] [Related]  

  • 58. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Nathan DM; Buse JB; Davidson MB; Heine RJ; Holman RR; Sherwin R; Zinman B; ;
    Diabetologia; 2006 Aug; 49(8):1711-21. PubMed ID: 16802130
    [No Abstract]   [Full Text] [Related]  

  • 59. Diabetology and oncology meet in a network model: union is strength.
    Gallo M; Gentile L; Arvat E; Bertetto O; Clemente G
    Acta Diabetol; 2016 Aug; 53(4):515-24. PubMed ID: 26862082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N of 1 trials in diabetes: making individual therapeutic decisions.
    Tsapas A; Matthews DR
    Diabetologia; 2008 Jun; 51(6):921-5. PubMed ID: 18389212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.